Table 1.
Characteristics of COVID-19 patients, by the presence of olfactory disorder.
| Characteristics | No. (%) of patientsa |
||
|---|---|---|---|
| Total, n = 5 | With olfactory disorder, n = 3 | Without olfactory disorder, n = 2 | |
| Demographics | |||
| Age, yrs | |||
| Mean ± SD | 25.6 ± 6.6 | 23.3 ± 2.1 | 29.0 ± 11.3 |
| Sex | |||
| Female | 4 (80.0) | 3 (100.0) | 1 (50.0) |
| Male | 1 (20.0) | 0 | 1 (50.0) |
| Symptoms | |||
| Fever on admission | 1 (20.0) | 0 | 1 (50.0) |
| Body temperature | |||
| <37.5 °C | 3 (60.0) | 2 (66.7) | 1 (50.0) |
| 37.5–38.0 °C | 1 (20.0) | 1 (33.3) | 0 |
| >38.0 °C | 1 (20.0) | 0 | 1 (50.0) |
| Gustatory disorder | 1 (20.0) | 1 (33.3) | 0 |
| Rhinorrhea | 3 (60.0) | 2 (66.7) | 1 (50.0) |
| Headache | 2 (40.0) | 1 (33.3) | 1 (50.0) |
| Cough | 3 (60.0) | 3 (100.0) | 0 |
| Sore throat | 2 (40.0) | 1 (33.3) | 1 (50.0) |
| Palpitation | 2 (40.0) | 2 (66.7) | 0 |
| Chest tightness | 2 (40.0) | 1 (33.3) | 1 (50.0) |
| Diarrhea | 1 (20.0) | 0 | 1 (50.0) |
| Mylgia or arthralgia | 1 (20.0) | 1 (33.3) | 0 |
| Coexisting disorders | |||
| Diabetes | 1 (20.0) | 0 | 1 (50.0) |
| Radiologic findings | |||
| Abnormalities on chest X-ray | 1 (20.0) | 0 | 1 (50.0) |
| Laboratory findings | |||
| Blood leukocyte count, per mm3 (mean ± SD) | 5970.0 ± 2047.1 | 4593.3 ± 472.6 | 8035.0 ± 1449.6 |
| Lymphocyte count, per mm3 (mean ± SD) | 1817.1 ± 480.8 | 1700.2 ± 570.4 | 2127.5 ± 232.9 |
| Platelet count, per mm3 (mean ± SD) | 2,36,000 ± 46,076 | 2,29,000 ± 34,641 | 2,46,500 ± 75,660 |
| Haemoglobin level – g/dl (mean ± SD) | 14.8 ± 0.5 | 14.8 ± 0.6 | 14.8 ± 0.3 |
| C-reactive protein level ≥ 10 mg/liter | 1 (20.0) | 0 | 1 (50.0) |
| Sodium – mmol/liter, mean ± SD | 135.8 ± 4.1 | 136.0 ± 5.3 | 135.5 ± 3.5 |
| Potassium – mmol/liter, mean ± SD | 3.9 ± 0.2 | 3.9 ± 0.2 | 4.0 ± 0.4 |
| Ferritin > 150 ng/ml | 3 (60.0) | 1 (33.3) | 2 (100.0) |
COVID-19, coronavirus disease 2019; SD, standard deviation.
a
Unless stated otherwise.